PBPH Among Health Care ETFs
End-of-day Nov 13, 2026 · 33 Health care ETFs by YTD
Loading…
Getting the latest data.
Portfolio Building Block ETFsSectorsHealth Care#38 of 263 by YTD
Portfolio Building Block ETFsSectorsHealth Care#38 of 263 by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | +0.4% | +1.8% | +8.2% | +13.2% | +25.3% | — | — | — | +26.2% |
| Peer average | −0.1% | +0.8% | +3.7% | +4.0% | +21.5% | +25.9% | +71.5% | +27.0% | — |
| S&P 500 · VOO | −0.4% | +2.6% | −2.3% | −2.1% | +11.5% | +11.6% | +79.3% | +72.7% | — |
$171 of every $1,000 in PBPH is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLY.TOELI Lilly | Healthcare | 17.08% | $1,708.05 | 164K | $235.8M |
| 2 | JNJ.TOJohnson & Johnson | Healthcare | 9.53% | $953.29 | 469K | $131.6M |
| 3 | ABBVAbbvie | Healthcare | 7.35% | $734.97 | 344K | $101.4M |
| 4 | MRKMerck | Healthcare | 5.13% | $512.78 | 481K | $70.8M |
| 5 | —Roche AG | — | 4.82% | $481.54 | 138K | $66.5M |
| 6 | AZN.LAstrazeneca | Healthcare | 4.69% | $468.92 | 351K | $64.7M |
| 7 | AMGNAmgen | Healthcare | 4.37% | $437.32 | 129K | $60.4M |
| 8 | NOVN.SWNovartis Ag-reg | Healthcare | 4.09% | $409.31 | 354K | $56.5M |
| 9 | GILD.TOGilead Sciences | Healthcare | 4.05% | $405.44 | 330K | $56.0M |
| 10 | PFE.BAPfizer | Healthcare | 3.24% | $323.70 | 1.5M | $44.7M |
| 11 | VRTXVertex Pharmaceuticals | Healthcare | 2.66% | $265.73 | 67K | $36.7M |
| 12 | —Novo Nordisk A/s-b | — | 2.49% | $248.85 | 849K | $34.3M |
| 13 | BMYBristol-myers Squibb | Healthcare | 2.48% | $247.75 | 544K | $34.2M |
| 14 | SAN.PASanofi | Healthcare | 2.00% | $200.41 | 288K | $27.7M |
| 15 | REGNRegeneron Pharmaceuticals | Healthcare | 1.83% | $183.41 | 26K | $25.3M |
Official documents are being connected from SEC EDGAR: […]. Read the issuer’s prospectus before investing.
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 24, 2025 | Dec 26, 2025 | $0.0230 |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY.TO | ELI Lilly & | 17.08% |
| 2 | JNJ.TO | Johnson & Johnson | 9.53% |
| 3 | ABBV | Abbvie | 7.35% |
| 4 | MRK | Merck & | 5.13% |
| 5 | AZN.L | Astrazeneca | 4.69% |
| 6 | AMGN | Amgen | 4.37% |
| 7 | NOVN.SW | Novartis Ag-reg | 4.09% |
| 8 | GILD.TO | Gilead Sciences | 4.05% |
| 9 | PFE.BA | Pfizer | 3.24% |
| 10 | VRTX | Vertex Pharmaceuticals | 2.66% |